Diplomat to Release Third Quarter Operating Results and Host Conference Call on Monday, November 10, 2014

News provided by

Oct 27, 2014, 04:18 ET

FLINT, Mich., Oct. 27, 2014 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, will release its third quarter 2014 operating results on Monday, November 10, 2014 after market close, with a conference call to follow at 5:00p.m. Eastern Time.

Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 877-201-0168 or 647-788-4901 for international callers, and referencing participant code 25799604 approximately 15 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of the Company's website and an audio file of the call will also be archived for 90 days at ir.diplomat.is.

About Diplomat

Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients, and the rest falls into place." Today, that tradition continues – always focused on improving patient care and clinical adherence. For more information, visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.

INVESTOR CONTACT:

Bob East, Westwicke Partners
443.213.0500 | [email protected]

MEDIA CONTACT:

Jenny Cretu, Diplomat
810.768.9370 | [email protected]

Logo - http://photos.prnewswire.com/prnh/20140928/148820

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diplomat-to-release-third-quarter-operating-results-and-host-conference-call-on-monday-november-10-2014-926040829.html

SOURCE Diplomat Pharmacy, Inc.